Taxanes having a C10 carbonate substituent

Details Taxanes having a C10 carbonate substituent Taxanes having a C10 carbonate substituent

2007-08-14

2007-08-14

Owens, Amelia A. (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C337S403000, C337S403000, C337S403000, C546S281700, C549S060000, C549S471000, C549S510000

Reexamination Certificate

active

11330770

ABSTRACT:
Taxanes having a methylcarbonate or ethylcarbonate substituent at C(10), a hydroxy substituent at C(7), and a range of C(13) side chain substituents.

REFERENCES:
patent: 5175315 (1992-12-01), Holton
patent: 5227400 (1993-07-01), Holton et al.
patent: 5243045 (1993-09-01), Holton et al.
patent: 5254580 (1993-10-01), Chen et al.
patent: 5283253 (1994-02-01), Holton et al.
patent: 5350866 (1994-09-01), Holton et al.
patent: 5407674 (1995-04-01), Gabetta et al.
patent: 5430160 (1995-07-01), Holton
patent: 5475011 (1995-12-01), Ojima et al.
patent: 5556878 (1996-09-01), Kelley et al.
patent: 5567614 (1996-10-01), Patel et al.
patent: 5614645 (1997-03-01), Kingston et al.
patent: 5698712 (1997-12-01), Bombardelli et al.
patent: 5714513 (1998-02-01), Holton et al.
patent: 5721268 (1998-02-01), Holton et al.
patent: 5728849 (1998-03-01), Bouchard et al.
patent: 5780653 (1998-07-01), Tao et al.
patent: 5811452 (1998-09-01), Ojima et al.
patent: 5879929 (1999-03-01), Patel
patent: 5906990 (1999-05-01), Bouchard et al.
patent: 5912264 (1999-06-01), Wittman et al.
patent: 5939561 (1999-08-01), Bourzat et al.
patent: 5959125 (1999-09-01), Bouchard et al.
patent: 5965739 (1999-10-01), Kelly et al.
patent: 6100411 (2000-08-01), Ojima
patent: 6160135 (2000-12-01), Bouchard et al.
patent: 6214863 (2001-04-01), Bissery
patent: 6660866 (2003-12-01), Holton
patent: 7056946 (2006-06-01), Holton
patent: 0 558 959 (1993-09-01), None
patent: 0 590 267 (1994-04-01), None
patent: 0 590 267 (1994-04-01), None
patent: 0 600 571 (1994-06-01), None
patent: 0 604 910 (1994-07-01), None
patent: 0 629 701 (1994-12-01), None
patent: 0 639 577 (1995-02-01), None
patent: 0 712 854 (1996-05-01), None
patent: 9902425 (2001-04-01), None
patent: 9904046 (2001-04-01), None
patent: 10-045583 (1998-02-01), None
patent: 951134214 (1997-03-01), None
patent: WO93/23389 (1993-11-01), None
patent: WO94/13655 (1994-06-01), None
patent: WO94/20484 (1994-09-01), None
patent: WO96/13495 (1996-05-01), None
patent: WO96/38138 (1996-12-01), None
patent: WO97/09979 (1997-03-01), None
patent: WO97/32578 (1997-09-01), None
patent: WO97/42181 (1997-11-01), None
patent: WO98/02426 (1998-01-01), None
patent: WO99/09021 (1999-02-01), None
patent: WO 00/53592 (2000-09-01), None
patent: WO 01/57013 (2001-08-01), None
patent: WO 01/57031 (2001-08-01), None
Gueritte-Voegelein et al., “Relationships between the Structure of Taxol Analogues and Their Antimitotic Activity”,Journal of Medicinal Chemistry,(1991), pp. 992-998, vol. 34:3.
Gueritte Voegelein et al., “Chemical Studies of 10-Deacetyl Baccatin III. Hemisynthesis of Taxol Derivatives”,Tetrahedron Letters,(1986),pp. 4451-4460, vol. 42:16.
Kant et al., “A Chemoselective Approach to Functionalize the C-10 Position of 10-Deacetylbaccatin III. Synthesis and Biological Properties of Novel C-10 Taxol Analogues”,Tetrahedron Letters,(1994), pp. 5543-5546, vol. 35 :30.
Ojima et al., “Enantiopure Fluorine-Containing Taxoids: Potent Anticancer Agents and Versatile Probes for Biomedical Problems”,Journal of Fluorine Chemistry,(1999), pp. 3-10, vol. 97.
Ojima et al., “Synthesis and Structure-Activity Relationships of the Second-Generation Antitumor Taxoids: Exceptional Activity Against Drug-Resistant Cancer Cells”,Journal of Medicinal Chemistry,(1995), pp. 3889-3896, vol. 39.
Ojima et al., “Synthesis and Biological Activity of Novel 3′-Trifluoromethyl Taxoids”,Bioorganic&Medicinal Chemistry Letters,(1997), pp. 133-138, vol. 7:2.
Ojima et al., “Synthesis of Novel 3′-Trifluoromethyl Taxoids Through Effective Kinetic Resolution of Racemic 4-CF3-β-Lactams With Baccatins”,Chirality,(1997), pp. 487-494, vol. 9.
Straubinger et al., “Pharmacology and Antitumor Effect of Novel Placlitaxel Formulations” Chapter 8, Edited by G. Georg et al., Taxane Anticancer Agents, Basic Science and Current Status, ACS Symposium Series 583, 207th National Meeting of the American Chemical Society, San Diego, CA, (1994), pp. 111-123.
European Search Report for related EP Application No. 01118727 dtd Oct. 30, 2001.
Georgia Search Report from AP 2001 004501 dtd Feb. 6, 2003.
International Search Report from PCT/US01/03588 dtd Jun. 12, 2001.

Affiliated with

Also associated with

Rating

Taxanes having a C10 carbonate substituent does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Taxanes having a C10 carbonate substituent, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Taxanes having a C10 carbonate substituent will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3900318